1148
D. Sirbu et al. / Journal of Organometallic Chemistry 691 (2006) 1143–1150
4.6.1. {8-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a; 3,4-a0]
dinaphthalen-4yl)-quinoline}chloro(methyl)palladium (5)
360 mg (75%) white solid were obtained. 1H NMR
(CDCl3) d 10.03 (d, J 3.5, 1H, CH@N); 8.41 (d, J 8.35,
1H); 8.11 (d, J 8.05, 1H); 8.06 (d, J 8.85, 1H); 8.01–7.95
(m, 3H); 7.70–7.68 (m, 1H); 7.65 (d, J 8.85, 1H); 7.55–
7.51 (m, 2H); 7.45–7.42 (m, 2H); 7.38–7.32 (m, 3H); 7.18
(t, J 8.05, 1H); 7.12 (d, J 8.85, 1H); 0.69 (s, 3H, Pd–
CH3). 31P NMR: d 163.7. HRMS: Found, 564.8768
(M+ꢀCl); calc. for C30H21NO2PPd, 564.8773.
chloride. The pale yellow filtrate was evaporated under
vacuum and yellow oil was obtained; upon treatment with
hexane (3 · 3 ml) and drying under vacuum, the complexes
9–12 were obtained as powders (89–97% yield).
4.7.1. (Acetonitril-jN){8-(3,5-dioxa-4-phospha-cyclo-
hepta[2,1-a; 3,4-a0]dinaphthalen-4yl)-quinoline}methyl
palladium(+) hexafluoro phosphate (9)
A beige powder (316 mg) was obtained (96%). 1H NMR
(CD2Cl2) d 9.24 (s, 1H, CH@N); 8.61 (d, J 7.73, 1H); 8.26
(d, J 8.02, 1H); 8.15 (d, J 8.80, 1H); 8.09–8.05 (m, 3H); 7.66
(d, J 8.82, 1H); 7.61–7.57 (m, 2H); 7.52 (t, J 7.1, 1H); 7.42–
7.37 (m, 5H); 7.22 (t, J 10.0, 1H); 7.16 (d, J 8.82, 1H); 2.22
(s, 3H, NCCH3); 0.46 (s, 3H, PdCH3). 31P NMR: d 164.3,
ꢀ143.1 (PF6). 19F NMR: d ꢀ73 (d). HRMS: Found,
564.8765 (M+ꢀNCCH3ꢀPF6); calc. for C30H21NO2PPd,
564.8773.
4.6.2. {8-(1,3-Dioxa-2-phospha-benzo[a,c]cyclohepten-2-
yl)-quinoline}chloro(methyl)palladium (6)
Yellow crystals (276 mg, 69%) were obtained and were
1
analyzed by X-ray. H NMR (CDCl3) d 10.01 (d, J 4.05,
1H, CH@N); 8.42 (d, J 8.25, 1H); 8.15 (d, J 6.05, 1H);
7.67 (q, J 8.25, J 4.85, 1H); 7.60 (t, J 4.15, 2H, Ph); 7.54
(t, J 3.55, 2H, Ph); 7.44–7.40 (m, 4H, Ph); 7.15 (d, J 7.60,
2H); 0.82 (s, 3H, Pd–CH3). 31P NMR: d 162.2. HRMS:
Found, 464.0033 (M+ꢀCl); calc. for C22H17NO2PPd,
464.0026.
4.7.2. (Acetonitril-jN){8-(1,3-dioxa-2-phospha-dibenzo-
[a,c]cyclohepten-2-yl)-quinoline}methylpalladium(+)
hexafluoro phosphate (10)
A beige powder (277 mg) was obtained (97%). 1H NMR
(CD2Cl2) d 9.24 (s, 1H, CH@N); 8.62 (d, J 7.97, 1H); 8.31
(d, J 7.97, 1H); 7.92 (s, 1H); 7.74–7.64 (m, 3H, Ph); 7.57–
7.45 (m, 5H, Ph); 7.19 (d, J 7.08, 2H); 2.47 (s, 3H,
NCCH3); 0.63 (s, 3H, PdCH3). 31P NMR: d 162.9,
ꢀ143.1 (PF6). HRMS: Found, 464.0033 (M+ꢀNCCH3ꢀ
PF6); calc. for C22H17NO2PPd, 464.0026.
4.6.3. {8-(Di(1H-pyrrol-1-l)phosphino)-quinoline}chloro-
(methyl)palladium (7)
1
A yellow solid (280 mg, 78%) was obtained. H NMR
3
4
(CDCl3) d 9.95 (dd, J 4.83, J 1.56, 1H, CH@N); 8.44
3
4
3
(dt, J 8.34, J 1.83, 1H); 8.19 (d, J 8.08, 1H); 8.13 (q, J
4
3
4
9.74, J 7.20, 1H); 7.77 (t, J 8.27, 1H); 7.68 (q, J 6.57, J
4.84, 1H); 6.98 (s, 4H, CH@); 6.40 (s, 4H, CH@); 1.13
(d, J 2.17, 3H, Pd–CH3). 31P NMR: d 94.6. HRMS: Found,
412.7269 (M+ꢀCl); calc. for C18H17N3PPd, 412.7279.
4.7.3. (Acetonitril-jN){8-(di(1H-pyrrol-1-yl)phosphino)-
quinoline}methylpalladium(+) hexafluoro phosphate (11)
A light brown powder (242 mg) was obtained (92%). 1H
4.6.4. {8-(Dipyrrolidin-1-ylphosphino)quinoline}chloro-
(methyl)palladium (8)
3
4
NMR (CD2Cl2) d 9.25 (dd, J 4.74, J 1.45, 1H, CH@N);
1
A yellow solid 346 mg was obtained (95%). H NMR
3
8.62 (d, J 8.38, 1H); 8.33 (d, J 8.10, 1H); 8.23 (q, J 9.44,
3
4
(CDCl3) d 9.93 (s, 1H, CH@N); 8.34 (dt, J 8.29, J 1.72,
3
4
3
4J 6.71, 1H); 7.96 (q, J 6.62, J 4.80, 1H); 7.87 (dt, J
8.35, 4J 1.34, 1H); 7.01 (m, 4H, CH@); 6.52 (m, 4H,
CH@); 2.43 (s, 3H, NCCH3); 0.94 (s, 3H, Pd–CH3). 31P
NMR: d 97.76, ꢀ143.1 (PF6). HRMS: Found, 598.7443;
calc. for C20H20F6N4P2Pd, 598.7448.
3
1H); 8.04–8.00 (m, 2H); 7.69 (t, J 8.01, 1H); 7.57 (q, J
4
6.55, J 4.84, 1H); 3.25–3.17 (m, 8H, CH2); 1.89–1.79 (m,
8H, CH2); 0.85 (s, 3H, PdCH3). 31P NMR: d 95.5. 13C
NMR d 153.0, 149.1 (d), 138.0, 136.9 (d), 132.8, 131.3,
129.3 (d), 128.2, 127.0 (d), 122.6 (Ar); 48.2 (d, CH2);
26.1(d, CH2); 0.002 (PdCH3). HRMS: Found, 420.7912
(M+ꢀCl); calc. for C18H25N3PPd, 420.7919.
4.7.4. (Acetonitril-jN){8-(dipyrrolidin-1-ylphosphino)-
quinoline}methylpalladium (+) hexafluoro phosphate (12)
1
A pale yellow powder (237 mg) was obtained (89%). H
4.7. General procedure for the preparation of the methyl-
(acetonitrile)palladium complexes 9–12
NMR (CD2Cl2) d 9.25 (s, 1H, CH@N); 8.45 (dt, 3J 8.36, 4J
3
4
1.60, 1H); 8.10 (d, J 8.0, 1H); 8.05 (q, J 13.1, J 9.0, 1H);
7.88–7.85 (m, 1H); 7.76 (t, J 8.15, 1H); 3.23–3.14 (m, 8H,
CH2); 2.5 (s, 3H, CNCH3), 1.91–1.81 (m, 8H, CH2); 0.57
(s, 3H, Pd–CH3). 31P NMR: d 94.67, ꢀ143.1 (PF6). 13C
NMR d 153.5, 148.3 (d), 139.0, 135.8 (d), 133.3, 132.2
(d), 129.5 (d), 127.5 (d), 123.9 (Ar), 120.5 (CNCH3), 48.3
(d, CH2), 26.1 (d, CH2), 2.64 (CNCH3), ꢀ1.4 (PdCH3).
HRMS: Found, 420.7915 (M+ꢀNCCH3ꢀPF6); calc. for
C18H25N3PPd, 420.7919. Calc. for C20H28N4F6P2Pd
(606.83): C, 39.59; H, 4.65; N, 9.23. Found: C, 40.00; H,
4.99; N, 8.90%.
In a two-neck, 50-ml flask covered with aluminum foil,
chloro(methyl)palladium complexes 5–8 (0.44 mmol) were
dissolved in 5 ml of a mixture of dichloromethane/acetoni-
trile (5:1, v/v) under argon and cooled to 0 ꢁC. The AgPF6
(0.44 mmol), dissolved in a 3-ml solution of dichlorometh-
ane/acetonitrile (5:1, v/v), was added to the mixture
through a dropping funnel. The reaction mixture was stir-
red for 1 h at 0 ꢁC and was warmed to ambient tempera-
ture, at which it was maintained for another hour.
Filtration through Celite removed the precipitated silver